Skip to main content

ARST0332 Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age

NCT00346164

Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age

Associated Conditions

Bone Cancer

Principal Investigator

Sponsor

Children's Oncology Group

This study is being done to find out: If treatment based on each subject's level of risk will get rid of the tumor and if lessening the treatment for lower risk subjects will decrease the side effects of treatment and still get rid of the tumor.